In Pennsylvania, this alleged illegal activity forced consumers and government agencies to pay much higher prices for the brand-name, anti-anxiety drug, ... It appears Bristol-Myers Squibb attempted to manipulate federal drug regulations to extend the patent and continue its monopoly on the product.

-Mike Fisher

Select a background
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image
Awesome background image

More quotes by Mike Fisher